The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 3,675 | 312,500 | SH | OTR | 312,500 | 0 | 0 | ||
ARADIGM CORP | COM PAR | 038505400 | 6,700 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 91,303 | 825,000 | SH | OTR | 825,000 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 58,632 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
BELLEROPON THERAPEUTICS INC | COM | 078771102 | 4,791 | 1,857,143 | SH | OTR | 1,857,143 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 18,853 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 10,348 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 9,319 | 1,012,986 | SH | OTR | 1,012,986 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 52,672 | 800,000 | SH | OTR | 800,000 | 0 | 0 | ||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 12,483 | 629,179 | SH | OTR | 629,179 | 0 | 0 | ||
GTX INC DEL | COM NEW | 40052B207 | 7,185 | 565,291 | SH | OTR | 565,291 | 0 | 0 | ||
INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 2,610 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 22,635 | 450,000 | SH | OTR | 450,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 12,925 | 844,789 | SH | OTR | 844,789 | 0 | 0 | ||
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 8,608 | 267,500 | SH | OTR | 267,500 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 41,800 | 2,200,000 | SH | OTR | 2,200,000 | 0 | 0 | ||
MEDICINES COMPANY | COM | 584688105 | 20,505 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 25,048 | 1,372,510 | SH | OTR | 1,372,510 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 68,173 | 2,726,938 | SH | OTR | 2,726,938 | 0 | 0 | ||
ONCONOVA THERAPEUTICS INC | *W EXP 07/07/202 | 68232V116 | 133 | 241,644 | SH | OTR | 241,644 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 29,190 | 1,750,000 | SH | OTR | 1,750,000 | 0 | 0 | ||
REGULUS THERAPEUTICS INC | COM | 75915K101 | 2,286 | 2,197,802 | SH | OTR | 2,197,802 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 12,183 | 3,140,000 | SH | OTR | 3,140,000 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 4,889 | 1,325,000 | SH | OTR | 1,325,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 876 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 19,305 | 550,000 | SH | OTR | 550,000 | 0 | 0 |